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Research Fellowship Programs in the Department of 
Health Policy 
With the concern over rising health care costs and the growing need for economic 
analysis of disease management strategies, the idea of enhancing clinical education 
with a fellowship program focusing on economic and outcomes research is both 
appealing and appropriate. The primary purpose of these fellowship programs is to 
provide formal training as well as experience in conducting pharmacoeconomic and 
outcomes research, as it occurs in academic, industry, and clinical settings. The 
Department of Health Policy at Thomas Jefferson University Hospital currently offers 
four such fellowship training programs. Three of these programs have been 
sponsored by Sandoz Pharmaceuticals, Rhone-Poulenc Rorer, and SmithKline 
Beecham and are conducted in conjunction with the Philadelphia College of Pharmacy 
and Science. The fourth fellowship is offered by Thomas Jefferson's Department of 
Surgery along with the Department of Health Policy. These types of collaborative 
efforts are unique and are expected to strengthen the skills of the fellowship trainees 
as well as Jefferson's ability to prosper in the changing health care environment.  
Upon the completion of the fellowship programs, the graduates will be well qualified 
to practice in roles that involve formulary decisions, evaluating the 
pharmacoeconomic literature, and identifying, designing, and conducting new 
research. The need for similar programs is evidenced by the growing number of 
applicants for the limited number of fellowship positions available. The Department 
of Health Policy is pleased to welcome the following four individuals to our staff.  
Richard Solit, MD is a graduate of Jefferson Medical College and received his BA in 
economics from the University of Pennsylvania. After having completed the first two 
years of post-graduate training in General Surgery at Thomas Jefferson University 
Hospital, Richard is now spending one year as surgical fellow with the Department of 
Health Policy. Richard hopes to combine his solid clinical training with experience in 
the policy and economics of medicine. Currently, he is involved in several projects 
including the evaluation of outcomes improvement following process changes for the 
Delaware Valley Transplant Program, as well as investigating admission criteria that 
contribute to variation in length of stay for a national for-profit rehabilitation 
corporation. In addition, Richard is studying part time at Widener University towards 
his MBA degree.  
Phong Duong is the SmithKline Beecham Pharmacoeconomics Fellow. After 
completing his undergraduate study from Temple University School of Pharmacy, he 
practiced as a pharmacist in both hospital and community settings. Phong received 
his PharmD degree from the Philadelphia College of Pharmacy & Science this past 
spring. Phong's areas of interest include cost-effectiveness evaluation, quality of life 
assessment, and international health care delivery and payment. His current project 
work includes economic evaluation of antibiotic stepdown programs at ten 
community hospitals as well as working on a study that addresses the appropriate 
use of ACR inhibitors in congestive heart failure patients.  
John Fastenau, the Sandoz Pharmaceutical Fellow, completed his MPH degree at 
Boston University School of Public Health and received his BS degree in pharmacy 
from Rutgers University. His prior experiences include drug safety surveillance 
John Fastenau: Research Fellowship Programs in the Department of Health Policy 
Health Policy Newsletter  Vol. 8, Number 3 (September 1995), Article 8
research as well as hospital and community pharmacy practice. John's current areas 
of interest include study design methodologies, statistical analytical techniques, and 
health care delivery systems within the United States and abroad. His current project 
work includes identifying and prioritizing outcomes of NSAID-induced gastrointestinal 
complications in long-term care facility residents and evaluating the use of 
Betaseron¨ in treating multiple sclerosis patients at a local health maintenance 
organization. John will also be assisting our staff in coordinating the monthly Health 
Policy Forum and tri-annual Newsletter.  
Vijay Nadipelli, the Rhone-Poulenc Rorer Pharmacoeconomics Fellow, is a registered 
pharmacist from India and is also a qualified Foreign Pharmacy Graduate in the 
United States. Vijay's zeal for advanced education in the field of pharmacy motivated 
him to relocate two years ago to Athens, Georgia and attend the University of 
Georgia where he received his MS degree in pharmacy administration. He is currently 
involved in several projects including one at the Philadelphia College of Pharmacy 
and Science which involves identifying, prioritizing, and benchmarking the standard 
of practice in the management of acid-peptic disorders in long-term care facility 
residents. Vijay will be taking various courses relevant to pharmacoeconomics during 
the fall and spring semesters at the University of Pennsylvania and the Philadelphia 
College of Pharmacy and Science. Phong and John will also be enrolled in classes at 
these academic institutions.  
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